Skip to main content
. 2013 Feb 27;4(3):154–164. doi: 10.1007/s12672-013-0135-0

Table 1.

Summary of patient characteristics

Number Age at diagnosis
Sample set 1
Benign serous cystadenoma 11 57 years (28–88)
Borderline tumor 9 49 years (31–61)
Serous ovarian cancer 46 63 years (27–86)
 Stage
 1 11
 2 12
 3 14
 4 9
 Grade
 1 3
 2 5
 3 37
 n.d. 2
 Overall survival 48.6 months (4.4–226.7)
Sample set 2
Primary and patient-matched metastatic cancer 23 66 years (49–87)
 Stage
 3 23
 Grade
 1 1
 2 4
 3 18
 Overall survival 23.9 months (0.10–58.3)

n.d. not determined